Clinical Trial Update: A Study of Sotatercept in Japanese Pulmonary Arterial Hypertension (PAH) Participants (MK-7962-020) [Phase 3]

View source ↗

Summary

Phase 3 trial update for sotatercept in Japanese patients with pulmonary arterial hypertension; the study is completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Arterial Hypertension

Drugs mentioned

• Sotatercept (sotatercept)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Pulmonary Arterial Hypertension | Phase 3 | Status: COMPLETED | Results posted: 2025-02-27